<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, the latest update provided by WHO on 17 June 2020 regarding the assessment of hydroxychloroquine as a treatment for COVID-19 infection notifies that this part of the SOLIDARITY trial was suspended based on the evidence gathered according to which hydroxychloroquine had no impact on decreasing the mortality of hospitalized COVID-19 patients as compared with standard care. Similar results were furnished by the United Kingdomâ€™s Recovery Trial, DisCoVeRy trial, and a Cochrane review, which also stopped their study [
 <xref rid="B107-jcm-09-02084" ref-type="bibr">107</xref>].
</p>
